Search
Purple Biotech Ltd
PPBTAdd to Watchlist
1.330USD
-0.110-7.64%
Close 10-09 16:00（ET）
1.24MMarket Cap
LossP/E TTM
Purple Biotech Ltd (PPBT) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Purple Biotech Ltd in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.000USD+1064.38%
PPBT Analyst Recommendation Trends
In the current month, PPBT has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PPBT average Analyst price target in the last month is 17.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
PPBT Analyst Rating for Peer Comparison
Updated: Oct 9, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
18
0
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Tempus AI Inc
TEM
4
7
11
0
1
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
Based on analysts' estimates, PPBT EPS is projected to reach -2.880 in FY2026Q3, following reported EPS of 0.400 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.40
-0.38
0.35
-2.88
-3.00
Actual
-2.54
-0.10
0.40
--
--
Surprise
+25.18%
+73.68%
+14.29%
--
--
FAQs
What is Purple Biotech Ltd's price target?
Analysts forecast that Purple Biotech Ltd's price target is USD 17.00, with the highest forecast at USD 17.00 and the lowest forecast at USD 17.00.
How have Purple Biotech LtdPPBT's recent earnings per share performed?
The market expectation was USD 0.40, while Purple Biotech LtdPPBT's earnings per share (EPS) for the previous quarter was USD -0.10. EPS for the next quarter is expected at USD -2.88.
What is the analyst rating for Purple Biotech Ltd?
Based on the ratings of Purple Biotech Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.